Cortendo closes about $26.4 mln in a private placement
Cortendo AB has raised about $26.4 million in a private placement. The investors were RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.
12 February 2015•2 mins read
